Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Walt

Showing results (241-250 of 277) with videos related to

Pageof 28
Sort By:
Nature Biomedical Engineering|August 8, 2022
A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasmaDevora Najjar, Joshua Rainbow, Sanjay Sharma Timilsina, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Attomolar fecal cytokine profiling reveals gut immune dynamics and disease statesStephanie J Zhang, Utkarsh Sharma, Yasmeen Senussi, et al.
Nature Biotechnology|May 25, 2010
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrationsDavid M Rissin, Cheuk W Kan, Todd G Campbell, et al.
Clinical Chemistry|September 8, 2020
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe DiseaseAlana F Ogata, Adam M Maley, Connie Wu, et al.
The Journal of Applied Laboratory Medicine|July 1, 2021
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Analytical Chemistry|June 19, 2015
The Scope of Analytical ChemistryJonathan V Sweedler, Daniel W Armstrong, Yoshinobu Baba, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Open Forum Infectious Diseases|August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2026
Differences in SARS-CoV-2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER-Adult Cohort StudyNaomi J Patel, Zoe Swank, Jiaqi Wang, et al.
Pageof 28

Showing results (241-250 of 277) with videos related to

Sort By:
Pageof 28
Nature Biomedical Engineering|August 8, 2022
A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasmaDevora Najjar, Joshua Rainbow, Sanjay Sharma Timilsina, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Attomolar fecal cytokine profiling reveals gut immune dynamics and disease statesStephanie J Zhang, Utkarsh Sharma, Yasmeen Senussi, et al.
Nature Biotechnology|May 25, 2010
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrationsDavid M Rissin, Cheuk W Kan, Todd G Campbell, et al.
Clinical Chemistry|September 8, 2020
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe DiseaseAlana F Ogata, Adam M Maley, Connie Wu, et al.
The Journal of Applied Laboratory Medicine|July 1, 2021
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Analytical Chemistry|June 19, 2015
The Scope of Analytical ChemistryJonathan V Sweedler, Daniel W Armstrong, Yoshinobu Baba, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Open Forum Infectious Diseases|August 31, 2022
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Jennifer L Crombie, ChiAn Cheng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2026
Differences in SARS-CoV-2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER-Adult Cohort StudyNaomi J Patel, Zoe Swank, Jiaqi Wang, et al.
Pageof 28